Jaypirca (pirtobrutinib) is currently available at specialty pharmacies. Eligibility for access may depend on your insurance coverage and the specific pharmacy network.
How do I get Jaypirca from my pharmacy?
To obtain Jaypirca, you will typically need a prescription from your healthcare provider. Your provider's office or a dedicated patient support program can assist with verifying insurance coverage and coordinating with specialty pharmacies for dispensing. These programs often help manage the prescription process and may offer financial assistance resources.
What is Jaypirca used to treat?
Jaypirca is an oral medication approved for adults with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a Bruton's tyrosine kinase (BTK) inhibitor [1]. It is also approved for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least one prior therapy [1].
How does Jaypirca work?
Jaypirca is a kinase inhibitor that targets Bruton's tyrosine kinase (BTK) [1]. BTK is a protein involved in the signaling pathways of certain white blood cells, and inhibiting it can help control the growth of cancer cells in MCL, CLL, and SLL.
What is the cost of Jaypirca?
The cost of Jaypirca can vary significantly based on insurance coverage, pharmacy, and any available patient assistance programs. For specific pricing information, it is advisable to consult with your healthcare provider and the pharmacy where the prescription will be filled.
When does the patent for Jaypirca expire?
Information regarding the specific patent expiration dates for Jaypirca (pirtobrutinib) is available through resources that track drug patents. For detailed patent information and timelines, DrugPatentWatch.com may provide relevant data [2].
Are there alternatives to Jaypirca for MCL or CLL/SLL?
Yes, there are other treatment options available for relapsed or refractory MCL, CLL, and SLL, depending on the patient's specific situation and prior treatments. These may include other BTK inhibitors, chemotherapy, or immunotherapy. Your healthcare provider can discuss the most appropriate treatment plan for your individual needs.